← Eichor
Condition: Low Grade Astrocytoma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Low Grade Astrocytoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Phase 3 · 132 location(s) · National Cancer Institute (NCI) · NCT04166409
HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)
NA · 1 location(s) · Dartmouth-Hitchcock Medical Center · NCT06930846
USPIO Enhanced MR Imaging in CNS Tumours (UMIC)
NA · 1 location(s) · Northern Care Alliance NHS Foundation Trust · NCT06572475
SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma
Phase 1/Phase 2 · 1 location(s) · St. Jude Children's Research Hospital · NCT04923126
Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade Glioma
Phase 3 · 1 location(s) · Sun Yat-sen University · NCT01649830
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
NA · 2 location(s) · St. Jude Children's Research Hospital · NCT04065776
Pediatric Low Grade Glioma - MEKinhibitor TRIal vs Chemotherapy
Phase 2 · 25 location(s) · University Hospital, Strasbourg, France · NCT05180825
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.